MAD2L1BP Activators
MAD2L1BP activators are conceptualized here as compounds that indirectly influence the functional activity or expression of MAD2L1BP through modulation of cell cycle dynamics, spindle assembly checkpoint regulation, or cellular stress mechanisms. Compounds like Nocodazole and Taxol, which disrupt or stabilize microtubules respectively, activate the spindle assembly checkpoint and potentially increase the reliance on MAD2L1BP's regulatory role. Proteasome inhibitors such as MG-132 [Z-Leu- Leu-Leu-CHO] and Bortezomib can increase cellular stress and the need for stringent checkpoint control, thereby potentially enhancing MAD2L1BP function in maintaining genomic stability. DNA damaging agents like Mitomycin C and Fluorouracil induce a cellular response that likely involves activation of the spindle checkpoint, increasing the functional demands on proteins like MAD2L1BP.
Kinase inhibitors, including Roscovitine and UCN-01, might also affect MAD2L1BP activity by altering the regulation of cell cycle progression and checkpoint controls. Compounds with broader cellular effects, such as DL-Sulforaphane, Curcumin, and Cholecalciferol, might influence MAD2L1BP activity by changing cellular growth conditions, inducing stress responses, or modulating checkpoint activation. Collectively, these compounds, through their varied effects on the cell cycle, cellular stress, and checkpoint regulation, contribute to the potential modulation of MAD2L1BP activity, highlighting the intricate network of cell cycle control and genomic stability maintenance. These activators underscore the complexity of targeting specific protein functions within the cell cycle machinery and the broader regulatory roles played in cellular physiology. This approach reflects the multifaceted strategies required to influence proteins like MAD2L1BP, integral to critical cellular processes such as mitosis and genomic integrity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule polymerization, leading to cell cycle arrest at the mitotic phase. This disruption can activate the spindle assembly checkpoint and may indirectly enhance the functional activity of MAD2L1BP as part of the checkpoint response. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 [Z-Leu- Leu-Leu-CHO] is a proteasome inhibitor that can increase cellular levels of ubiquitinated proteins. By inhibiting protein degradation, MG-132 [Z-Leu- Leu-Leu-CHO] might lead to increased cellular stress and a heightened need for checkpoint controls, potentially enhancing the role of MAD2L1BP. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a cyclin-dependent kinase (CDK) inhibitor that can halt cell cycle progression. By modulating CDK activity, it might influence the spindle assembly checkpoint and thereby affect MAD2L1BP activity. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C is a DNA crosslinking agent that can induce DNA damage and cell cycle arrest. This DNA damage response might activate the spindle assembly checkpoint and increase the reliance on MAD2L1BP's regulatory functions. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor used by preventing the degradation of ubiquitinated proteins, it can indirectly affect cell cycle regulation and possibly enhance the function of MAD2L1BP in the spindle checkpoint. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane is a compound known for its anticancer properties, partly through inducing cell cycle arrest and apoptosis. It may indirectly influence MAD2L1BP activity by modulating cell cycle checkpoints and stress responses. | ||||||
UCN-01 | 112953-11-4 | sc-202376 | 500 µg | $251.00 | 10 | |
UCN-01 is a kinase inhibitor with effects on cell cycle progression and checkpoint control. It might indirectly affect MAD2L1BP's activity by altering the regulation of the spindle assembly checkpoint. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol has been shown to influence cell proliferation and apoptosis. It might affect MAD2L1BP activity indirectly by modulating cell cycle dynamics and checkpoint controls in certain cell types. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin affects various cellular pathways, including those involved in cell cycle regulation and stress response. It might indirectly influence MAD2L1BP activity by altering the cellular environment and demands on the spindle checkpoint. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can lead to cell cycle arrest in G1 phase. While primarily affecting G1/S transition, its broad effects on cell growth and proliferation might indirectly influence spindle checkpoint proteins like MAD2L1BP. | ||||||